pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 7·1 min read
save

STAT+ warns that employer-sponsored health insurance is deteriorating, leaving workers and businesses exposed

Jul 7, 2026·read at STAT ↗Negative

Bob Herman's latest STAT+ newsletter introduces a new series called Out of Pocket, Out of Reach, which will examine how the employer-based health-insurance system is falling apart.

The article notes that most U.S. workers receive health coverage through their jobs, but rising costs and stagnant wages are eroding the value of that benefit. It suggests that earnings have quietly suffered over time as insurance premiums increase.

Herman calls the situation a crisis, saying it is arguably never been worse and is unlikely to improve without major changes. He invites readers to share personal experiences about how job-based coverage affects them.

For pharmaceutical companies and investors, the weakening of employer coverage could influence drug pricing negotiations and market access, making the trend an important factor to watch.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: America’s employer health insurance is decaying”

read at STAT ↗
523 words · retrieved Jul 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING
topics
Major Depression

related stories

  • Aug 19Trump's FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: AnalystsBioSpace
  • Aug 14Nascent US psychedelic therapy opportunity attracts overseas manufacturersBioSpace
  • Jul 31Syphilis spreads while researchers contend with federal constraints and a drug shortageSTAT
  • Jul 18‘A rising tide scenario’: Why other Big Pharmas could follow Lilly into psychedelicsFierce Biotech
  • Jul 2The new presidential fitness test is a positive step, not the solution, experts saySTAT